Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Improving the ex vivo stability of drug ester compounds in rat and dog serum: inhibition of the specific esterases and implications on their identity.

Koitka M, Höchel J, Gieschen H, Borchert HH.

J Pharm Biomed Anal. 2010 Feb 5;51(3):664-78. doi: 10.1016/j.jpba.2009.09.023. Epub 2009 Sep 23.

PMID:
19850433
2.

Determination of rat serum esterase activities by an HPLC method using S-acetylthiocholine iodide and p-nitrophenyl acetate.

Koitka M, Höchel J, Obst D, Rottmann A, Gieschen H, Borchert HH.

Anal Biochem. 2008 Oct 1;381(1):113-22. doi: 10.1016/j.ab.2008.06.019. Epub 2008 Jun 18.

PMID:
18602882
3.

Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.

Hoffmann J, Bohlmann R, Heinrich N, Hofmeister H, Kroll J, Künzer H, Lichtner RB, Nishino Y, Parczyk K, Sauer G, Gieschen H, Ulbrich HF, Schneider MR.

J Natl Cancer Inst. 2004 Feb 4;96(3):210-8.

PMID:
14759988
4.

The bioavailability of oral fludarabine phosphate is unaffected by food.

Oscier D, Orchard JA, Culligan D, Cunningham D, Johnson S, Parker A, Klein M, Gieschen H.

Hematol J. 2001;2(5):316-21.

PMID:
11920267
5.

Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma.

Gieschen HL, Spiro IJ, Suit HD, Ott MJ, Rattner DW, Ancukiewicz M, Willett CG.

Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):127-31.

PMID:
11316555
7.

A pilot study of concomitant boost accelerated superfractionated radiotherapy for stage III cancer of the uterine cervix.

Kavanagh BD, Gieschen HL, Schmidt-Ullrich RK, Arthur D, Zwicker R, Kaufman N, Goplerud DR, Segreti EM, West RJ.

Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):561-8.

PMID:
9231680
8.

Development of a V79 cell line expressing human cytochrome P450 2D6 and its application as a metabolic screening tool.

Rauschenbach R, Gieschen H, Salomon B, Kraus C, Kühne G, Hildebrand M.

Environ Toxicol Pharmacol. 1997 Feb 15;3(1):31-9.

PMID:
21781755
9.

Clinical use of a digital simulator for rapid setup verification in high dose rate brachytherapy.

Zwicker RD, Atari NA, Kavanagh BD, Gieschen HL, Arnfield MR, Khandelwal SR, Schmidt-Ullrich RK.

Int J Radiat Oncol Biol Phys. 1995 Nov 1;33(4):931-6.

PMID:
7591905
10.

Stable expression of human cytochrome P450 3A4 in V79 cells and its application for metabolic profiling of ergot derivatives.

Rauschenbach R, Gieschen H, Husemann M, Salomon B, Hildebrand M.

Eur J Pharmacol. 1995 Oct 6;293(3):183-90.

PMID:
8666035
11.

Studies on the biotransformation of lonazolac, bromerguride, lisuride and terguride in laboratory animals and their hepatocytes.

Hümpel M, Sostarek D, Gieschen H, Labitzky C.

Xenobiotica. 1989 Apr;19(4):361-77.

PMID:
2750201

Supplemental Content

Loading ...
Support Center